 |
|
Abstracts: In Other Archives Journals
Arch Facial Plast Surg. 2006;8(5):350-351.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Archives of Dermatology
Use of Polylactic Acid Implants to Correct Facial Lipoatrophy in Human Immunodeficiency Virus 1–Positive Individuals Receiving Combination Antiretroviral Therapy
Objective: To assess the efficacy, safety, and tolerability of facial injections of polylactic acid for human immunodeficiency virus (HIV) 1–associated facial lipoatrophy, which commonly affects HIV-1–infected patients receiving combination antiretroviral therapy.
Design: A cohort of 50 consecutive HIV-1–infected outpatients with moderate to severe facial lipoatrophy who were receiving antiretroviral therapy were recruited in one institutional center and followed up for 12 months. Patients received the compound subcutaneously at baseline and on days 30, 45, and 60 of the study, for a total of 4 sets of injections; if necessary, 2 additional sets of injections were allowed on days 75 and 90. At enrollment and during follow-up, data on patients' characteristics, facial ultrasonography, and iconography were assessed. Data for 2 questionnaires, on self-perception of severity of facial lipoatrophy and on quality of . . . [Full Text of this Article]
Archives of Neurology
Archives of Otolaryngology–Head & Neck Surgery
Archives of Surgery
|
